Article Information
- Received November 10, 2008
- Revision received December 26, 2008
- Accepted January 13, 2009
- First published March 18, 2009.
- Version of record published March 18, 2009.
Author Information
- 1Neuroregeneration Laboratories, Harvard Medical School, McLean Hospital, Belmont, Massachusetts 02478,
- 2Harvard Neurodiscovery Center, Boston, Massachusetts 02114, and
- 3Morris K. Udall Parkinson's Disease Research Center of Excellence, Belmont, Massachusetts 02478
- Correspondence should be addressed to Dr. Ole Isacson and Dr. Chee Yeun Chung, Neuroregeneration Laboratories, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478. isacson{at}hms.harvard.edu; and cychung{at}mclean.harvard.edu
Author contributions
Disclosures
- Received November 10, 2008.
- Revision received December 26, 2008.
- Accepted January 13, 2009.
-
This work was conducted at McLean Hospital and was supported by funds to O.I. from the National Institutes of Health/National Institute of Neurological Disorders and Stroke P50 (Grant NS39793), Parkinson's Disease Udall Research Centers of Excellence to McLean/Harvard Medical School, the Michael Stern Foundation for Parkinson's Disease Research, the Consolidated Anti-Aging Foundation, and Harold and Ronna Cooper Family. We thank Dr. Vikram Khurana for discussion and critical reading of this manuscript and Casper Reske-Nielsen, Kari Ording, Alyssa Yow, and Raymond Johnson for their excellent technical assistance. We also thank Dr. Pavel Oston for kindly providing AAV2 synapsin GFP construct.
-
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Ole Isacson and Dr. Chee Yeun Chung, Neuroregeneration Laboratories, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478. isacson{at}hms.harvard.edu; and cychung{at}mclean.harvard.edu
Online Impact